In Search of a New FDA Commissioner

In one of the most widely expected departures in recent memory, Marty Makary stepped down as head of the FDA this week. 

Meanwhile, the Supreme Court is considering blocking telehealth prescriptions for the abortion pill mifepristone. 

Lauren Weber of The Washington Post, Alice Miranda Ollstein of Politico, and Rachel Cohrs Zhang of Bloomberg News join KFF Health News’ Julie Rovner to discuss these stories and more. 

Also this week, Rovner interviews Sen. Tammy Baldwin (D-Wis.) about health issues before Congress. 

Visit our website for a transcript of this episode.

Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too: 

Julie Rovner: ProPublica’s “A Unique Oregon Law Allows It To Block Healthcare Deals. In Five Years, the State Hasn’t Done So Once,” by Rob Davis. 

Rachel Cohrs Zhang: The Wall Street Journal’s “Inside Marty Makary’s Downfall at the FDA,” by Liz Essley Whyte and Josh Dawsey.  

Alice Miranda Ollstein: Politico’s “Lawmakers’ Prescription Data at Risk After Data Breach,” by Katherine Tully-McManus.  

Lauren Weber: Stat’s “Alcohol Is Wreaking Havoc on U.S. Public Health. American Society Looks the Other Way,” by Lev Facher and Isabella Cueto.